Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Plafibride |
EINECS | N/A |
CAS No. | 63394-05-8 | Density | 1.251g/cm3 |
PSA | 79.90000 | LogP | 2.33260 |
Solubility | N/A | Melting Point |
100-102° |
Formula | C16H22 Cl N3 O4 | Boiling Point | N/A |
Molecular Weight | 355.821 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Experimental teratogenic and reproductive effects. Used as an antithrombotic agent. When heated to decomposition it emits very toxic fumes of Cl− and NOx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
ITA 104;Idonor; Perifunal; Plafibride |
Article Data | 2 |
Product Name: Plafibride (CAS NO.63394-05-8)
Molecular Formula: C16H22ClN3O4
Molecular Weight: 355.86g/mol
Mol File: 63394-05-8.mol
Einecs: 264-121-2
Density: 1.251 g/cm3
Surface Tension: 46.3 dyne/cm
XLogP3-AA: 2.4
H-Bond Donor: 2
H-Bond Acceptor: 5
Structure Descriptors of Plafibride (CAS NO.63394-05-8):
IUPAC Name: 2-(4-chlorophenoxy)-2-methyl-N-(morpholin-4-ylmethylcarbamoyl)propanamide
Canonical SMILES: CC(C)(C(=O)NC(=O)NCN1CCOCC1)OC2=CC=C(C=C2)Cl
InChI: InChI=1S/C16H22ClN3O4/c1-16(2,24-13-5-3-12(17)4-6-13)14(21)19-15(22)18-11-20-7-9-23-10-8-20/h3-6H,7-11H2,1-2H3,(H2,18,19,21,22)
InChIKey: DDDQVDIPBFGVIG-UHFFFAOYSA-N
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
guinea pig | LD50 | oral | 2168mg/kg (2168mg/kg) | Archivos de Farmacologia y Toxicologia. Vol. 4, Pg. 137, 1978. | |
hamster | LD50 | intraperitoneal | 880mg/kg (880mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. | |
hamster | LD50 | oral | > 4gm/kg (4000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. | |
mouse | LD50 | intraperitoneal | 710mg/kg (710mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. | |
mouse | LD50 | intravenous | 126mg/kg (126mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. | |
mouse | LD50 | oral | 3365mg/kg (3365mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. | |
rat | LD50 | intraperitoneal | 975mg/kg (975mg/kg) | Archivos de Farmacologia y Toxicologia. Vol. 4, Pg. 137, 1978. | |
rat | LD50 | intravenous | 95mg/kg (95mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. | |
rat | LD50 | oral | > 4gm/kg (4000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. |
Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Experimental teratogenic and reproductive effects. Used as an antithrombotic agent. When heated to decomposition it emits very toxic fumes of Cl− and NOx.
Plafibride ,its CAS NO. is 63394-05-8,the synonyms is 1-(2-(p-Chlorophenoxy)-2-methylpropionyl)-3-(morpholinomethyl)urea ; BRN 0569805 ; EINECS 264-121-2 ; ITA-104 ; Idonor ; N'-Morpholinomethylurea, N-2-(p-chlorophenoxy)isobutyryl- ; N-2(p-Chlorophenoxy)-2-methylpropionyl-N'-morpholinomethylurea ; N-2(p-Chlorophenoxy)isobutyryl-N'-morpholinomethylurea ; Perifunal ; Plafibridum ; UNII-5J7C4JZ564 ; Propanamide, 2-(4-chlorophenoxy)-2-methyl-N-(((4-morpholinylmethyl)amino)carbonyl)- .